Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: FYI Holocom.. Question for SHM?

<As stated in Note 11, in February 2007, we invested an aggregate of $370,000 in Holocom for 2,100,000 shares of convertible preferred stock. >

Is there reasons why PTSC has not converted the preferred shares? Would seem to me that demand after 9/11 would have made such a move obvious. Are there any restrictions on such conversion?

Opty

Share
New Message
Please login to post a reply